Fletcher Lee Hartsell

Journal Article Mult Scler Relat Disord · January 2023 BACKGROUND: Neuromyelitis optica spectrum disorder (NMOSD) is a rare autoimmune neurological disorder associated with antibodies to aquaporin-4 (AQP4). NMOSD has been thought to follow a progressive disease course, with step-wise accumulation of disability ... Full text Open Access Link to item Cite

Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease: Presentation and outcomes of adults at a single center.

Journal Article J Neuroimmunol · December 15, 2022 BACKGROUND/INTRODUCTION: Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is a chronic demyelinating disorder that has been increasingly recognized since the serum antibody became commercially available in 2017. The most common clini ... Full text Open Access Link to item Cite

Disability prediction in multiple sclerosis using performance outcome measures and demographic data

Conference Proceedings of Machine Learning Research · January 1, 2022 Literature on machine learning for multiple sclerosis has primarily focused on the use of neuroimaging data such as magnetic resonance imaging and clinical laboratory tests for disease identification. However, studies have shown that these modalities are n ... Cite

The clinical presentation and treatment of MOG antibody disease at a single academic center: A case series.

Journal Article J Neuroimmunol · December 15, 2019 OBJECTIVES: To describe the clinical presentation of MOG antibody disease (MOG-AD) in a series of patients at a single academic center. METHODS: We performed a retrospective review of patients with MOG antibodies. RESULTS: We review the clinical presentati ... Full text Link to item Cite

Fletcher Lee Hartsell

Selected Publications

Neuromyelitis optica: Clinical course and potential prognostic indicators.

Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease: Presentation and outcomes of adults at a single center.

Disability prediction in multiple sclerosis using performance outcome measures and demographic data

The clinical presentation and treatment of MOG antibody disease at a single academic center: A case series.

A Risk Aversion Calculator for Augmenting the Disease Modifier Selection Process

Current Correlations between Disease Modifiers and Physiologic Measurements from the MS Mosaic Study

Current Correlations between Disease Modifiers and Symptom Experiences from the MS Mosaic Study

Patient Feedback on MS Mosaic Study's App Design